Lineage 2–Beijing Mycobacterium tuberculosis strains suppress BCG-trained innate immunity early after infection

Read full text Summarise with VIRAT
Authors: Naomi J. Daniels, Todia Pediatama Setiabudiawan, Taru S. Dutt, Philip C. Hill, Marcela I. Henao-Tamayo, Reinout van Crevel, Joanna R. Kirman
Cited by: 0
References: 52

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Summary Genetically distinct lineages of Mycobacterium tuberculosis differ in their virulence, transmissibility, and immune evasion capacity. The modern Lineage 2-Beijing (L2-B) clade of Mtb , which is highly prevalent in Asia and now globally distributed, is associated with resistance to the bacille Calmette Guérin (BCG) vaccine. Using a murine BCG vaccination model followed by aerosol challenge with geographically matched L2-B or Lineage 4 clinical isolates, we examined how L2-B circumvents vaccine-induced immunity. BCG-trained alveolar macrophages showed impaired control of L2-B growth in vitro . Spatial transcriptomic profiling of infected lungs revealed broad transcriptional reprogramming, including selective suppression of pathways essential for macrophage activation and trained innate immunity. Similar immune dysregulation was observed in peripheral blood from BCG-vaccinated household contacts of L2-B smear-positive TB patients. Together, these findings suggest mechanisms of lineage-specific immune evasion in TB, highlight key components of BCG-induced protection, and support re-evaluation of current TB vaccine strategies.

Fields of Study & Subjects

Tuberculosis Research and Epidemiology Immune responses and vaccinations Infectious Diseases and Tuberculosis

Publication details

Journal / source
bioRxiv (Cold Spring Harbor Laboratory)
Publication date
1 April 2026
Language
EN
Document type
Preprint